Micro- and nanoplastics: A new cardiovascular risk factor?
Xiaoqi Zhu, Chuanxuan Wang, Xiaoyu Duan...
https://pubmed.ncbi.nlm.nih.gov/36473237/Actively Recruiting
Led by Azienda Ospedaliera "Sant'Andrea" · Updated on 2025-05-11
130
Participants Needed
10
Research Sites
52 weeks
Total Duration
Researchers are studying the presence of micro- and nanoplastics MNPs in patients who have had a specific type of heart attack called ST segment elevation acute myocardial infarction STEMI. The study aims to understand how MNPs found in coronary blood clots relate to heart damage, plaque vulnerability, microvascular obstruction, and future heart-related events. This observational study will use imaging techniques like optical coherence tomography and cardiac magnetic resonance to explore these connections. The study involves patients undergoing urgent coronary angiography and thromboaspiration to remove blood clots. Researchers will compare those with MNPs in their clots to those without. Various assessments include measuring MNP levels in different vessels and biological samples, evaluating heart muscle damage, and analyzing plaque composition. The study will follow participants for up to one year to monitor heart events and recovery. Participants will undergo evaluations from enrollment through hospital discharge, including blood tests for inflammation and heart damage, imaging assessments, and monitoring of heart function and complications. Follow-up visits will occur up to one year after enrollment to assess cardiovascular events and heart function recovery. The primary outcomes focus on the burden of MNPs in coronary thrombi and their association with biomarkers and cardiac damage during the hospital stay, with extended observation for longer-term heart health outcomes.
CONDITIONS
Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
E
Emanuele Barbato, MD, PhD
C
Clinical Research Unit Cardiology Dept. Sant'Andrea University Hospital
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Azienda Ospedaliera "Sant'Andrea"
Lead Sponsor
University of Campania Luigi Vanvitelli
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 7 days
Participants undergo urgent invasive coronary angiography and thromboaspiration to assess the presence of micro- and nanoplastics (MNPs) during ST-elevation myocardial infarction (STEMI).
1 to 2 visits during hospital stay
Duration - Up to 1 year
Participants are monitored for cardiovascular outcomes including left ventricular recovery, recurrence of angina and myocardial infarction, and major adverse cardiovascular events (MACE) over time.
Follow-up visits at 3 months and 1 year post-enrollment
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Xiaoqi Zhu, Chuanxuan Wang, Xiaoyu Duan...
https://pubmed.ncbi.nlm.nih.gov/36473237/Sheng Liu, Chenyang Wang, Yunxiao Yang...
https://pubmed.ncbi.nlm.nih.gov/38428296/Francesco Prattichizzo, Antonio Ceriello, Valeria Pellegrini...
https://pubmed.ncbi.nlm.nih.gov/39240674/Tingting Wang, Zhiheng Yi, Xiaoqiang Liu...
https://pubmed.ncbi.nlm.nih.gov/38614011/Yunxiao Yang, Feng Zhang, Zhili Jiang...
https://pubmed.ncbi.nlm.nih.gov/39164741/Duk-Hee Lee
https://pubmed.ncbi.nlm.nih.gov/39283932/Raffaele Marfella, Francesco Prattichizzo, Celestino Sardu...
https://pubmed.ncbi.nlm.nih.gov/38446676/Azienda Ospedaliera "Sant'Andrea"
Lead Sponsor
University of Campania Luigi Vanvitelli
Collaborating Sponsor